ATP5F1B and cancer: Multiple mechanisms may initiate this switch, one of which is a decrease in the expression of the beta subunit of ATP synthase (F1) (ATP5B), leading to the disruption of the catalytic function of the ATP synthase complex, an event that has been previously observed in multiple cancer types [50], [51].